Hi Reader,
Do you remember the days you were buildling houses in Lego bricks?
Building the house of your dreams, but then getting frustrated as you couldn't find that specific 3-dotted thin brick you needed according to plan? Of having to start it all over because you skipped that one crucial step? Or did you prefer to play around, ignoring any provided plan?
And now, as an adult?
Do you build your dream house brick by brick, working yourself to blood sweat and tears? Or do you consult an architect for plans and expert knowledge on the best materials? And turn to professional builders with state-of-the-art equipment to build a durable structure?
Building a data strategy is like building a house, but one of data insights.
The life cycle of a medicine is a collection of data bricks, merging into larger trends.
From EMA authorisation, market access to off-patent price erosion, there is a bulk of data to collect and learn from.
A smart strategist follows those trends to anticipate and adapt to a competitive environment.
Data is ubiquitous, but the sources of information are scattered. And let's face it, some bricks are harder to handle as they reside in unstructured formats such as pdf files or websites.
Assembling data bricks into houses of insights doesn’t come easily. It requires a unique and scarce combination of data-expertise and technical skills.
Do no longer manually sweat yourself through data puzzles, but uncover all potential. Turn to a data architect with domain expertise and focus on building a proactive and competitive strategy.
We can be of help to you.
It is Digile's mission to connect the medicinal data dots.
It is time to connect the data dots from all silos, and build up-to-date insights to anticipate the ever faster changing medical market.
Dear Reader, can you help me out with the following questions?
Thinking of your current data strategy...
Let me know in a small reply, as I'm alway happy to hear from you.
Have a nice day, Team Farmanaut >> follow us on LinkedIn
Want to learn how to easily integrate drug data, monitor changes and construct timelines for the European and Belgian drug market? Then subscribe to our newsletter and learn from our data experts. Nice to have you on board :-)
Hi Reader, “We sometimes feel like a helpdesk”, the market access manager confessed, ‘but it’s mission impossible to keep track of all label extensions, changes to reimbursement criteria and upcoming launches for every possible competitor’. And she continued: “During holiday periods or with staff turnover, we get particularly stressed to keep track of all the information, stored in multiple Excel spreadsheets that need to be permanently updated and exchanged between colleagues”. Is continuity...
Hi Reader, "Hi, can we plan for a Farmaneut demo?" Farma-what? Farma-neut? As I started to visualize this new type of unhappy and somewhat grumpy medical professional, a wave of doubt made its way through my body. But soon thereafter, a warm feeling of thriving ambition made its way back to me, producing a big smile on my face. We love our customers for their enthusiasm but far underestimated their creativity. When developing market intelligence software, we felt like astronauts exploring...
Hi Reader, “It’s not about creating a digital strategy for our business but about creating a business strategy for a digital world.” A quote from Lidia Fonseca. As Pfizer’s Chief Digital and Technology Officer, Lidia is responsible for all data and technology solutions across the organization. Organizations need to adapt to the changing environment and implement digital and data in their everyday operations and workflow. But I hear you think… where do I start? I’m already using data, right?...